Pfizer's Accounting Method Leads to Higher Effective Tax Rate in U.S.

Pfizer’s accounting methods raise its reported tax rate, without increasing the actual taxes the company pays. More than two-thirds of the company’s 2014 tax expense—$2.2 billion out of $3.1 billion—was money the company will actually pay only if and when it chooses to repatriate foreign profits.

from WSJ.com: US Business http://ift.tt/1MtDOrc
via IFTTT